Form 8-K - Current report:
SEC Accession No. 0000950170-25-038861
Filing Date
2025-03-13
Accepted
2025-03-13 17:00:09
Documents
13
Period of Report
2025-03-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jagx-20250313.htm   iXBRL 8-K 61521
2 EX-99.1 jagx-ex99_1.htm EX-99.1 24328
3 GRAPHIC img107817981_0.jpg GRAPHIC 87080
  Complete submission text file 0000950170-25-038861.txt   326677

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT jagx-20250313.xsd EX-101.SCH 24902
15 EXTRACTED XBRL INSTANCE DOCUMENT jagx-20250313_htm.xml XML 4708
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 25736660
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)